SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $337M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 10 closing their positions.
Holders
79
Holders Change
+1
Holders Change %
+1.28%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
36
Reduced
16
Closed
10
Calls
$593K
Puts
$679K
Net Calls
-$86K
Net Calls Change
+$281K
Top Buyers
Top Sellers
1 |
1
Goldman Sachs
New York
|
$501K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$30.1M |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$44.7M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$0 |
5 |
5
Morgan Stanley
New York
|
$69.4M |